Purdue Pharma and its owners, the Sackler family,Latest lawsuits have agreed to a new settlement totaling up to $7.4 billion to resolve extensive litigation related to the opioid crisis. This agreement replaces a previous settlement that was invalidated by the U.S. Supreme Court. The funds are designated primarily for state and local governments to support addiction treatment and prevention programs, with $800 to $850 million allocated for direct payments to victims. The settlement also includes provisions for future claims, setting aside $800 million. Despite the financial penalties, the Sackler family continues to deny any wrongdoing. This development marks a significant step in addressing the opioid epidemic, which has resulted in hundreds of thousands of deaths since OxyContin's release in 1996.

<div class="relative inline-flex items-center"> </div>

technical SEO, white-hat <span style="font-family: Arial; font-size: 10pt;">mozconcepts </span>SEO, black-hat SEO, gray-hat SEO, canonical URLs, schema markup, structured data, robots.txt, XML sitemap, crawl budget, Googlebot, indexation, noindex, dofollow, nofollow, 301 redirect, 302 redirect, URL structure, breadcrumb navigation, user intent, semantic search, LSI keywords, search volume, CTR, bounce rate, dwell time, conversion rate, organic traffic, paid traffic, referral traffic, keyword